Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Invested Capital: 2010-2022

Historic Return on Invested Capital for Anika Therapeutics (ANIK) over the last 12 years, with Dec 2022 value amounting to 0.00%.

  • Anika Therapeutics' Return on Invested Capital was N/A to 0.05% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.05%, marking a year-over-year change of. This contributed to the annual value of 0.00% for FY2022, which is N/A change from last year.
  • Anika Therapeutics' Return on Invested Capital amounted to 0.00% in FY2022, which was up 100.42% from -0.08% recorded in FY2020.
  • In the past 5 years, Anika Therapeutics' Return on Invested Capital ranged from a high of 0.10% in FY2019 and a low of -0.08% during FY2020.
  • For the 2-year period, Anika Therapeutics' Return on Invested Capital averaged around -0.04%, with its median value being -0.04% (2020).
  • As far as peak fluctuations go, Anika Therapeutics' Return on Invested Capital increased by 3bps in 2019, and later declined by 18bps in 2020.
  • Anika Therapeutics' Return on Invested Capital (Yearly) stood at 0.06% in 2018, then rose by 3bps to 0.10% in 2019, then dropped by 18bps to -0.08% in 2020, then reached 0.00% in 2022.